News & Analysis on Clinical Trial Services & Contract Research And Development
Scientists at the Babraham Institute in the UK have discovered that a tiny change in a protein involved in cell survival is responsible for abnormal cell activity in the early stages of cancer. Understanding how the cancer gets going in the first...
Dowpharma has developed new strains of the bacterium Pseudomonas fluorescens that can be used to improve the yield of recombinant proteins made in fermentation vats.
German contract ingredient manufacturer Girindus posted its first profit since it was floated on the stock exchange in 2000 in the last quarter of 2003, as sales rose 16 per cent to €32 million.
Bespak has reported declining sales and profits at its half-yearly results, but said the figures showed that a recovery plan was on track.
UK-headquartered NextGen Sciences has formed an alliance with Germany's Protagen aimed at developing 'biochips' that can contain thousands of functional proteins for use in drug discovery.